Redwood City, CA, United States of America

John McLean


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 195(Granted Patents)


Company Filing History:


Years Active: 1998-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: John McLean: Innovator in Cationic Lipid Compositions

Introduction

John McLean is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of cationic lipid compositions. With a total of 8 patents to his name, McLean's work focuses on innovative solutions for targeting angiogenic endothelial cells.

Latest Patents

Among his latest patents, McLean has developed compositions that utilize cationic liposomes to selectively target angiogenic endothelial cells. One of his notable inventions involves cationic lipid compositions that can inhibit or promote the growth of these targeted cells. This technology allows for precise localization of angiogenesis by administering cationic liposomes containing detectable labels. Additionally, he has created a method for the cationic liposome delivery of taxanes to angiogenic blood vessels, further enhancing the therapeutic potential of his inventions.

Career Highlights

John McLean is affiliated with the University of California, where he continues to advance his research in lipid-based drug delivery systems. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of angiogenesis and its implications in various medical conditions.

Collaborations

Some of McLean's notable coworkers include Donald M McDonald and O Gavin Thurston. Their collaborative efforts have further enriched the research landscape in which McLean operates.

Conclusion

John McLean's contributions to the field of cationic lipid compositions have paved the way for new therapeutic strategies targeting angiogenic endothelial cells. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…